1 link tagged with all of: clinical-trials + de-risking + antivirals
Click any tag below to further narrow down your results
Links
A new $500 million fund backed by Stripe, Anthropic and others will support drugs and air filtration tech aimed at preventing colds, flu and other respiratory viruses. It plans to shepherd at least two therapies through Phase I/II trials and pilot air-cleaning systems in offices to de-risk them for larger investors.